Lv41
610 积分 2024-02-07 加入
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
6天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
11天前
已完结
B Cell Development and Maturation
1个月前
已完结
Chimeric antigen receptor T cell therapy for autoimmune disease
1个月前
已完结
Mechanisms of central tolerance for B cells
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
1个月前
已完结
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
1个月前
已完结
CAR T-cell therapy in autoimmune diseases
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
Mechanisms of Tissue Injury in Lupus Nephritis
1个月前
已完结
皖公网安备34019202002308
